Clinical trial
Efficacy and Activity of BAY 43-9006 in Patients With Recurrent and/or…
NCT00199160 · Jules Bordet Institute, Other · Completed
Key facts
| NCT number | NCT00199160 |
|---|---|
| Title | Efficacy and Activity of BAY 43-9006 in Patients With Recurrent and/or Metastatic Head and Neck Cancer |
| Lead sponsor | Jules Bordet Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Neoplasms |
| Intervention type | Drug |
| Interventions | BAY 43-9006 |
| Enrollment | 60 |
| Start date | Apr 1, 2005 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Sep 20, 2005 |
| Last update posted | May 20, 2015 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: